Company Name:AC Immune SA
CEO: Andrea Pfeifer

Sector: Health Technology

Exchange: NASDAQ

Country: CH

Description: AC Immune SA engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.

Key numbers

Market Capitalization:476425170
Shares Outstanding: 71859000
Float: 38203909
Next Earning Date:2020-08-05
TTm EPS: -0.3648
TTm Dividend Rate:
200 days moving average:7.35
50 days moving average: 7.11
One day percent Change: 7.5

2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,